Search
Now showing items 1-2 of 2
The interactions of azure B, a metabolite of methylene blue, with 2 acetylcholinesterase and butyrylcholinesterase
(Elsevier, 2014)
Methylene blue(MB) is reported to possess diverse pharmacological actions and is attracting increasing attention
for the treatment of neurodegenerative disorders such as Alzheimer's disease. Among the pharmacological
actions ...
Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties
(Elsevier, 2014)
Aims: The phenothiazinium compound, methylene blue (MB), possesses diverse pharmacological actions and is
attracting attention for the treatment of bipolar disorder and Alzheimer's disease. MB acts on both monoamine
oxidase ...